Food Standards (Application A1174 – Xylanase from Trichoderma reesei as a Processing Aid (Enzyme)) Variation

Administered by Department of Health, Disability and Ageing

Legislation au F2020L00568 Not in force Legislative Instrument

Legislation content

Explanatory statement

1. Authority

 

Section 13 of the Food Standards Australia New Zealand Act 1991 (the FSANZ Act) provides that the functions of Food Standards Australia New Zealand (the Authority) include the development of standards and variations of standards for inclusion in the Australia New Zealand Food Standards Code (the Code).

 

Division 1 of Part 3 of the FSANZ Act specifies that the Authority may accept applications for the development or variation of food regulatory measures, including standards. This Division also stipulates the procedure for considering an application for the development or variation of food regulatory measures.

 

The Authority accepted Application A1174, which seeks permission to use endo-1,4-beta-xylanase from a genetically modified strain of Trichoderma reesei as a processing aid in the manufacture of bakery products and other cereal-based products, including cereal-based beverages. The Authority considered the application in accordance with Division 1 of Part 3 and has approved a draft variation to the Code.

 

Following consideration by the Australia and New Zealand Ministerial Forum on Food Regulation, section 92 of the FSANZ Act stipulates that the Authority must publish a notice about the standard or draft variation of a standard.  

 

Section 94 of the FSANZ Act specifies that a standard, or a variation of a standard, in relation to which a notice is published under section 92 is a legislative instrument, but is not subject to parliamentary disallowance or sunsetting under the Legislation Act 2003.

 

2. Purpose

 

The Authority has approved an amendment to the table to subsection S18––9(3) in Schedule 18 of the Code to permit the use of endo-1,4-beta-xylanase from a genetically modified strain of Trichoderma reesei as a processing aid in the manufacture of bakery and other cereal-based products, including cereal-based beverages.

 

3. Documents incorporated by reference

 

The variations to food regulatory measures do not incorporate any documents by reference.

 

Existing provisions of the Code incorporate a document by reference that will prescribe identity and purity specifications for the processing aid to be permitted by the draft variation. Section 1.1.1—15 of the Code requires substances used as processing aids to comply with any relevant identity and purity specifications listed in Schedule 3 of the Code. Section S3—2 of Schedule 3 incorporates by reference the specifications listed in the Joint FAO/WHO Expert Committee on Food Additives (JECFA) Compendium of Food Additive Specifications (FAO/WHO 2017) and the United States Pharmacopeial Convention (2018) Food Chemicals Codex (11th edition). These include specifications for enzyme preparations used in food processing.

 

4. Consultation

 

In accordance with the procedure in Division 1 of Part 3 of the FSANZ Act, the Authority’s consideration of Application A1174 included one round of public consultation following an assessment and the preparation of a draft variation and associated assessment summary.  Submissions were called for on 24 September 2019 for a six-week consultation period.

 

The Office of Best Practice Regulation (OBPR) granted the Authority a standing exemption from needing to develop a Regulatory Impact Statement for proposed variations of the Code to permit additional processing aids (OBPR correspondence dated 24 November 2010 - reference 12065). This standing exemption was provided as permitting additional processing aids is likely to have only a minor impact on business and individuals. It is a minor, deregulatory change that allows for the introduction of a processing aid to the food supply that has been determined to be safe. The use of the approved processing aid is also voluntary.

 

5. Statement of compatibility with human rights

 

This instrument is exempt from the requirements for a statement of compatibility with human rights as it is a non-disallowable instrument under section 94 of the FSANZ Act.

 

6. Variation

 

The variation inserts a new entry into the table to subsection S18—9(3) in Schedule 18.

 

The new entry would permit the use of endo-1,4-beta-xylanase (EC 3.2.1.8) sourced from Trichoderma reesei containing the endo-1,4-beta-xylanase gene from Aspergillus niger as a processing aid.

 

The specific technological purpose for the permission is the manufacture of bakery and other cereal-based products, including cereal-based beverages.

 

A condition of the permission is that the maximum permitted level or amount that may be used must be consistent with good manufacturing practice.

 

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.